ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : Industry : ALL_STUDIES


Include trials that are no longer recruiting patients.

846 studies were found. Here are studies 1 to 50.
1.Recruiting"REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk
Condition: Prostate Cancer
2.RecruitingA 14-day study of Racivir when used in combination in HIV-Infected Males
Condition: HIV Infections
3.Recruiting2 doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting
Condition: Postoperative Nausea and Vomiting
4.Recruiting2 Doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting
Condition: Postoperative Nausea and Vomiting
5.RecruitingA 20-week study of a new treatment for men with Benign Prostatic Hyperplasia (BPH).
Condition: Prostatic Hyperplasia
6.RecruitingA 24 Week Study of Daily Oral Investigational Drug vs Placebo in Patients with Asthma
Condition: Asthma
7.Recruiting3 Different Dose Levels Of CCI-779 In Subjects With Active Rheumatoid Arthritis On Concomitant Methotrexate Therapy
Condition: Rheumatoid Arthritis
8.Recruiting3 Fixed Dosages of Extended Release OROS Paliperidone and Olanzapine in the Treatment of Subjects with Schizophrenia
Condition: Schizophrenia
9.Recruiting3-AP and Gemcitabine in Treating Patients With Metastatic Non-Small Cell Lung Cancer
Conditions: recurrent non-small cell lung cancer; stage IV non-small cell lung cancer
10.Recruiting48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV Infection
Condition: HIV Infections
11.RecruitingA 6-week safety & efficacy study of combination intraocular pressure-lowering therapy in patients with open-angle glaucoma or ocular hypertension
Conditions: Glaucoma, Open-Angle; Ocular Hypertension
12.RecruitingA 6-week safety and efficacy study of Travatan compared to Xalcom in subjects with open-angle glaucoma(OAG) or ocular hypertension(OHT)
Conditions: Glaucoma, Open-Angle; Ocular Hypertension
13.RecruitingAbciximab (ReoPro) in Acute Ischemic Stroke
Condition: Stroke
14.RecruitingABX-EGF Monotherapy in Subjects with Metastatic Colorectal Cancer
Conditions: Colorectal Cancer; Metastases
15.RecruitingActive Crohn’s Disease Study
Condition: Crohn Disease
16.RecruitingAcute Glycemic Effects of a Very Low Fat Diet in Type 2 Diabetes
Condition: Diabetes Mellitus, Non-Insulin-Dependent
17.RecruitingAcute Myeloid Leukemia Study
Condition: Acute Myeloid Leukemia
18.RecruitingAdalimumab for the Induction and Maintenance of Clinical Remission in Subjects with Crohn’s Disease
Condition: Crohn's Disease
19.RecruitingAdjunct CellCept (mycophenolate mofetil) with Reduced Corticosteroids in Subjects with Myasthenia Gravis
Condition: Myasthenia Gravis
20.RecruitingAdvanced Or Metastatic Non-Small Cell Lung Cancer Study In Patients Who Have Received One Platinum-based Chemotherapy
Condition: Non-small cell lung cancer
21.RecruitingAdvanced Renal Cell Carcinoma
Conditions: Carcinoma, Renal Cell; Kidney Neoplasms
22.RecruitingAfrican-American Heart Failure Trial
Condition: Congestive Heart Failure
23.RecruitingAG-858 in Patients who are Cytogenetically Positive after Treatment with Gleevec™
Condition: Leukemia, Myeloid, Chronic
24.RecruitingAlfimeprase for thrombolysis in Acute Peripheral Arterial Occlusion
Conditions: Arterial Occlusive Diseases; Peripheral Vascular Diseases; Thrombosis
25.RecruitingAlimta (pemetrexed) and Cisplatin versus Gemzar (gemcitabine) and Cisplatin in Patients with Locally Advanced or Metastatic Non Small Cell Lung Cancer
Condition: Non Small Cell Lung Carcinoma
26.RecruitingALIMTA (pemetrexed) and Gemcitabine (gemzar) in Patients with Advanced Cancer
Condition: Neoplasms
27.RecruitingAlimta (pemetrexed) in Patients with Non-Small Cell Lung Cancer Who Have Failed a Prior Platinum-Containing Chemotherapy
Condition: Non-Small-Cell Lung Carcinoma
28.RecruitingAlimta (pemetrexed) plus Cisplatin Followed by Surgery and Radiation for Pleural Mesothelioma
Condition: Pleural Neoplasms
29.RecruitingALIMTA (pemetrexed) Plus Gemcitabine (Gemzar) for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer who have not had previous chemotherapy.
Condition: Carcinoma, Non-Small-Cell Lung
30.RecruitingALIMTA (pemetrexed) Plus Gemcitabine (Gemzar) for Patients with Malignant Pleural or Peritoneal Mesothelioma who have not had previous chemotherapy
Condition: Mesothelioma
31.RecruitingAlimta (pemetrexed) plus Gemzar (gemcitabine) in metastatic breast cancer patients after receiving Taxane therapy.
Condition: Breast Cancer
32.RecruitingAMG 162 in Biphosphonate Naive Metastatic Breast Cancer
Conditions: Breast Cancer; Metastases
33.RecruitingAMG 162 in the Treatment of Bone Loss in Subjects Undergoing Androgen-Deprivation Therapy for Non-metastatic Prostate Cancer
Condition: Prostate Cancer
34.RecruitingAMG 162 in the Treatment of Bone Loss in Subjects Undergoing Aromatase Inhibitor Therapy for Non-metastatic Breast Cancer
Condition: Breast Cancer
35.RecruitingAnastrozole Plus Lonafarnib (SCH 66336) or Plus Placebo for the Treatment of Advanced Breast Cancer
Condition: Breast Cancer
36.RecruitingAnastrozole With or Without Trastuzumab in Treating Postmenopausal Women With Metastatic Breast Cancer
Conditions: stage IV breast cancer; recurrent breast cancer
37.RecruitingAngiomax in Patients with HIT/HITTS Type II Undergoing CPB
Conditions: Cardiovascular Disease; Coronary Artery Bypass Surgery
38.RecruitingAngiomax in Patients with HIT/HITTS Type II Undergoing Off-Pump Coronary Artery Bypass Grafting (CABG) (CHOOSE)
Conditions: Thrombocytopenia; Thrombosis; Cardiac Disease; Coronary Artery Bypass Surgery
39.Not yet recruitingAnti-angiogenesis Agent AG-013736 in Patients with Advanced Non-Small Cell Lung Cancer
Conditions: Non-Small-Cell Lung Carcinoma; Metastases
40.Not yet recruitingAnti-angiogenesis Agent AG-013736 in Patients with Metastatic Melanoma
Conditions: Melanoma; Metastases
41.RecruitingAntibiotic Treatment for Patients with Infections of Short Term In-dwelling Vascular Catheters Due to a Specific Bacteria (Gram Positive Bacteria)
Conditions: Bacterial Infections; Gram-Positive Bacterial Infections; Bacteremia
42.RecruitingAntigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN) VP 104 Study
Condition: Alzheimer Disease
43.RecruitingARIES - Ambrisentan in Patients with Moderate to Severe Pulmonary Arterial Hypertension (PAH)
Condition: Pulmonary Hypertension
44.RecruitingArimidex in McCune Albright Syndrome
Condition: McCune-Albright Syndrome
45.RecruitingARISE – Aggressive Reduction of Inflammation Stops Events
Conditions: Atherosclerosis; Coronary Artery Disease; Myocardial Infarction; Unstable Angina
46.RecruitingARQ 501 in Subjects with Cancer
Condition: Cancer
47.Not yet recruitingAutologous Cultured Myoblasts (BioWhittaker) Transplanted via Myocardial Injection
Conditions: Congestive Heart Failure; Coronary Artery Disease; Myocardial Infarction
48.RecruitingAutologous Incubated Macrophages for Patients with Complete Spinal Cord Injuries
Condition: Spinal Cord Injury
49.RecruitingAutologous T Cell Immunotherapy for Chronic Lymphocytic Leukemia (CLL) Patients
Condition: Chronic Lymphocytic Leukemia
50.RecruitingAvastin With or Without Erlotinib for Treatment of Metastatic Renal Cell Carcinoma
Condition: Renal Cell Cancer

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act